RLMD
Relmada Therapeutics Inc
3.70$
-1.6%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.53 | -6.53 | -4.53 | -2.14 | -1.91 | 0.00 | -1.78 | -5.23 | -3.50 | -1.72 | -1.72 | -1.16 | |
| 0.00 | 0.00 | 0.02 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | |
| 0.80 | 0.32 | 0.42 | 0.23 | 0.17 | 0.00 | 1.33 | 2.31 | 1.49 | 1.46 | 1.00 | 0.38 | |
| 2.29 | -4.79 | -0.01 | 0.41 | 1.61 | 0.30 | 1.33 | 2.38 | 1.30 | – | – | – | |
| -0.45 | -0.45 | 0.58 | -0.08 | 0.22 | 0.00 | 0.70 | -0.45 | 0.36 | 0.10 | -0.05 | -0.10 | |
| 0.01 | 0.01 | 0.19 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -0.01 | -0.01 | -0.19 | -0.02 | 0.00 | -0.01 | -2.21 | -3.08 | 0.67 | 1.68 | 1.71 | -1.22 | |
| 5.41 | – | – | – | 5.66 | 12.34 | – | – | 1.44 | – | – | – | |
| -0.12 | -0.11 | -0.09 | 2.17 | -0.09 | -0.04 | -0.01 | 0.00 | 0.00 | – | – | – | |
| 5.29 | 5.29 | -0.09 | -0.09 | 2.09 | 0.01 | 1.83 | 10.71 | 1.52 | 0.00 | 0.00 | 2.37 | |
| -1.25 | -1.25 | -4.82 | -2.25 | 0.17 | 0.00 | -2.17 | 2.39 | -1.32 | -0.04 | -0.01 | -0.01 | |
| -6.54 | -6.54 | -4.73 | -2.16 | -1.92 | 0.00 | -1.78 | -5.23 | -3.50 | -1.72 | -1.72 | -1.16 |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.